Skip to content
GenoLensGenoLens

MYMX

Chr 6p21.1

myomixer, myoblast fusion factor

Aliases:
MINION
MANE:
ENST00000573382.3

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Congenital myopathy

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Carey-Fineman-Ziter syndrome

    0.61
  • Carey-Fineman-Ziter syndrome

    0.38
  • lymphatic system disorder

    0.09
  • ovarian neoplasm

    0.08
  • Congenital myasthenic syndromes

    0.07
  • Postsynaptic congenital myasthenic syndromes

    0.07
  • Hereditary proximal myopathy with early respiratory failure

    0.07
  • Bethlem myopathy

    0.07
  • congenital myasthenic syndromes with glycosylation defect

    0.07
  • Distal myopathy, Nonaka type

    0.07

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Protein myomixer

Myoblast-specific protein that mediates myoblast fusion, an essential step for the formation of multi-nucleated muscle fibers (PubMed:28569745, PubMed:35642635). Involved in membrane fusion downstream of the lipid mixing step mediated by MYMK (By similarity). Acts by generating membrane stresses via its extracellular C-terminus, leading to drive fusion pore formation. Acts independently of MYMK (By similarity). Involved in skeletal muscle regeneration in response to injury by mediating the fusion of satellite cells, a population of muscle stem cells, with injured myofibers (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.